Answers are grounded in this paper and cite their sources.
Objective Breast conserving surgery (BCS) has become the primary treatment for early breast cancer. We developed a novel approach, single-port three-dimensional endoscopic-assisted breast conserving surgery (S-P 3D E-BCS), aiming to enhance cosmetic outcomes without compromising oncological safety. Methods A total of 65 breast cancer patients who received S-P 3D E-BCS at Changhua Christian Hospital, Taiwan, China from July 2022 to August 2024 were enrolled in this retrospective study. The clinical outcomes, learning curve analysis with the cumulative sum (CUSUM) plot, and patient-reported outcomes via the Breast-Q were reported. Results S-P 3D E-BCS was conducted via the same axillary incision used for lymph node surgery. Our success rate of S-P 3D E-BCS was 100 %. The median E-BCS time was 170 min, and the median blood loss was 20 mL. The CUSUM plot revealed that the median operation time significantly decreased after the twelfth case. Focally microscopic margin involvement was reported in 4.6 % (3/65) of the patients. No severe complications were observed. The overall satisfaction of the cosmetic outcomes was 98.2 %. During the median follow-up of 25 months, none of the patients reported locoregional recurrence, distant metastasis or mortality. Conclusions S-P 3D E-BCS is a safe and feasible approach for breast cancer treatment, offering promising cosmetic outcomes.
No takes yet. Share an insight, caveat, or question.
Sae-lim et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: